270
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Besides Sarcopenia, Pre-Sarcopenia Also Predicts All-Cause Mortality in Older Chileans

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 611-619 | Published online: 15 Apr 2021

References

  • Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–256. doi:10.1016/j.jamda.2011.01.00321527165
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq03420392703
  • Delmonico MJ, Harris TB, Lee J-S, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55(5):769–774. doi:10.1111/j.1532-5415.2007.01140.x17493199
  • Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr. 2012;31(5):652–658. doi:10.1016/j.clnu.2012.02.00722414775
  • Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95(5):1851–1860. doi:10.1152/japplphysiol.00246.200314555665
  • Albala C, Sánchez H, Lera L, Angel B, Fuentes A, Arroyo P. Sarcopenia is more important than vitamin D deficiency as determinant of osteoporosis in Chilean elders. Osteoporos Int. 2012;23(Suppl 2):S343–S344.
  • Serra Rexach JA. [Clinical consequences of sarcopenia]. Nutr Hosp. 2006;21 Suppl 3(3):46–50. Spanish.16768030
  • Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332(9):556–561. doi:10.1056/NEJM1995030233209027838189
  • Cruz-Jentoft AJ, Landi F, Topinková E, Michel J-P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1–7. doi:10.1097/MCO.0b013e328333c1c119915458
  • Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing. 2013;42(2):203–209. doi:10.1093/ageing/afs19423321202
  • Bunout D, de la Maza MP, Barrera G, Leiva L, Hirsch S. Association between sarcopenia and mortality in healthy older people. Australas J Ageing. 2011;30(2):89–92. doi:10.1111/j.1741-6612.2010.00448.x21672118
  • Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2015;7(3):290–298. doi:10.1002/jcsm.1207327239410
  • Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018. doi:10.1093/ageing/afy169
  • WHO. World Population Report; 2020.
  • Lera L, Albala C, Sánchez H, et al. Prevalence of sarcopenia in community-dwelling Chilean elders according to an adapted version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria. J Frailty Aging. 2017;6(1):12–17. doi:10.14283/jfa.2016.11728244552
  • Alexandre TDS, Duarte YADO, Santos JLF, Wong R, Lebrao ML. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr Health Aging. 2014;18(8):751–756. doi:10.1007/s12603-014-0540-225286455
  • Samper-Ternent R, Reyes-Ortiz C, Ottenbacher KJ, Cano CA. Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study. Aging Clin Exp Res. 2016;1–8. doi:10.1007/s40520-016-0561-2
  • Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Pérez-Zepeda MU. Prevalence of sarcopenia in Mexico City. Eur Geriatr Med. 2012;3(3):157–160. doi:10.1016/j.eurger.2011.12.001
  • Batsis JA, Mackenzie TA, Barre LK. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the national health and nutrition examination survey III. Eur J Clin Nutr. 2014;68(9):1–7. doi:10.1038/ejcn.2014.11724398713
  • Hirani V, Blyth F, Naganathan V, et al. Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: the concord health and ageing in men project. J Am Med Dir Assoc. 2015;16(7):607–613. doi:10.1016/j.jamda.2015.02.00625820131
  • Landi F, Calvani R, Tosato M, et al. Impact of physical function impairment and multimorbidity on mortality among community-living older persons with sarcopaenia: results from the ilSIRENTE prospective cohort study. BMJ Open. 2016;6(7):e008281. doi:10.1136/bmjopen-2015-008281
  • Liu P, Hao Q, Hai S, Wang H, Cao L, Dong B. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas. 2017;103:16–22. doi:10.1016/j.maturitas.2017.04.00728778327
  • Albala C, Sánchez H, Lera L, Angel B, Cea X. [Socioeconomic inequalities in active life expectancy and disability related to obesity among older people]. Rev Med Chil. 2011;139(10):1276–1285. Spanish. doi:10.4067/S0034-9887201100100000522286726
  • Lera L, Albala C, Ángel B, et al. [Anthropometric model for the prediction of appendicular skeletal muscle mass in Chilean older adults]. Nutr Hosp. 2014;29(3):611–617. Spanish. doi:10.3305/nh.2014.29.3.706224559006
  • Lang IA, Llewellyn DJ, Alexander K, Melzer D. Obesity, physical function, and mortality in older adults. J Am Geriatr Soc. 2008;56(8):1474–1478. doi:10.1111/j.1532-5415.2008.01813.x18662211
  • Lera L, Angel B, Márquez C, Saguez R, Albala C. Software for the diagnosis of sarcopenia in community-dwelling older adults: design and Validation Study. JMIR Med Informatics. 2020;8(4):e13657. doi:10.2196/13657
  • Lera L, Ángel B, Sánchez H, et al. [Validation of cut points of skeletal muscle mass index for identifying sarcopenia in Chilean older people]. Nutr Hosp. 2015;31(3):1187–1197. Spanish. doi:10.3305/nh.2015.31.3.8054
  • Lera L, Albala C, Leyton B, et al. Reference values of hand-grip dynamometry and the relationship between low strength and mortality in older Chileans. Clin Interv Aging. 2018;13:317–324. doi:10.2147/CIA.S15294629503536
  • Yuki A, Ando F, Otsuka R, Shimokata H. Sarcopenia based on the Asian Working Group for Sarcopenia criteria and all-cause mortality risk in older Japanese adults. Geriatr Gerontol Int. 2017;17(10):1642–1647. doi:10.1111/ggi.1294628261905
  • Sim M, Prince RL, Scott D, et al. Sarcopenia definitions and their associations with mortality in older Australian women. J Am Med Dir Assoc. 2019;20(1):76–82.e2. doi:10.1016/j.jamda.2018.10.01630527277
  • Abramowitz MK, Hall CB, Amodu A, Sharma D, Androga L, Hawkins M. Muscle mass, BMI, and mortality among adults in the United States: a population-based cohort study. PLoS One. 2018;13(4). doi:10.1371/journal.pone.0194697
  • Li R, Xia J, Zhang X, et al. Associations of muscle mass and strength with all-cause mortality among US Older Adults. Med Sci Sports Exerc. 2018;50(3):458–467. doi:10.1249/MSS.000000000000144828991040
  • Kobayashi K, Ando K, Tsushima M, et al. Predictors of presarcopenia in community-dwelling older adults: a 5-year longitudinal study. Mod Rheumatol. 2019;29(6):1053–1058. doi:10.1080/14397595.2018.155117130474461
  • Petermann-Rocha F, Chen M, Gray SR, Ho FK, Pell JP, Celis-Morales C. New versus old guidelines for sarcopenia classification: what is the impact on prevalence and health outcomes? Age Ageing. 2020;49(2):300–304. doi:10.1093/ageing/afz12631728486
  • Locquet M, Beaudart C, Petermans J, Reginster J-Y, Bruyère O. EWGSOP2 Versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc. 2019;20(3):384–385. doi:10.1016/j.jamda.2018.11.02730661861